<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 15.1</label>
 <caption>
  <p>Phases of chronic hepatitis B infection</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Phase</th>
    <th>Laboratory results and histology</th>
    <th>Note</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="4">Immune tolerant</td>
    <td>HBsAg and HBeAg detectable</td>
    <td>Biopsy not indicated</td>
   </tr>
   <tr>
    <td>HBV DNA &gt;20,000 IU/mL (&gt;105 copies/mL)</td>
    <td>Antiviral therapies generally ineffective</td>
   </tr>
   <tr>
    <td>ALT normal</td>
    <td>Risk of drug resistance if treated with nucleos(t)ide analogs</td>
   </tr>
   <tr>
    <td>Absent or minimal liver inflammation and fibrosis</td>
    <td>Continued monitoring</td>
   </tr>
   <tr>
    <td rowspan="3">HBeAg + immune active</td>
    <td>HBsAg and HBeAg remain detectable</td>
    <td>Most asymptomatic</td>
   </tr>
   <tr>
    <td>HBV DNA &gt;20,000 IU/mL (&gt;105 copies/mL)</td>
    <td>Biopsy</td>
   </tr>
   <tr>
    <td>ALT persistently elevated</td>
    <td>Rule out other liver diseases</td>
   </tr>
   <tr>
    <td rowspan="5">Inactive HBsAg</td>
    <td>HBsAg present</td>
    <td>Age at serconversion influenced by HBV genotype</td>
   </tr>
   <tr>
    <td>HBeAg undetectable, anti-HBe present</td>
    <td>Risk of developing cirrhosis declines</td>
   </tr>
   <tr>
    <td>HBV DNA &lt;2,000 IU/mL (&gt;104 copies/mL) or undetectable</td>
    <td>Risk of developing HCC</td>
   </tr>
   <tr>
    <td>ALT normal</td>
    <td>Biopsy generally not indicated</td>
   </tr>
   <tr>
    <td>Absent or minimal liver inflammation, fibrosis regresses over time</td>
    <td>Continued monitoring</td>
   </tr>
   <tr>
    <td rowspan="5">Reactivation of HBeAg-negative, immune active</td>
    <td>HAsAg present</td>
    <td>Occurs in 20–30 % of patients</td>
   </tr>
   <tr>
    <td>HBeAg remains negative and anti-HBe positive</td>
    <td>“e-antigen-negative” hepatitis B</td>
   </tr>
   <tr>
    <td>HBV DNA levels &gt;2,000 IU/mL (&gt;104 copies/mL)</td>
    <td>Liver biopsy indicated, especially if ALT raised</td>
   </tr>
   <tr>
    <td>ALT normal or elevated</td>
    <td>Treatment should be considered if moderate/severe inflammation of fibrosis present</td>
   </tr>
   <tr>
    <td>Active liver inflammation ± fibrosis</td>
    <td/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Modified from Jonas et al. [
   <xref ref-type="bibr" rid="CR104">104</xref>]
  </p>
 </table-wrap-foot>
</table-wrap>
